Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Epirubicin Hydrochloride (DBL) 50 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (DBL) 100 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Actavis) 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epiccord 10 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (DBL) 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pharmorubicin 20 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epicin 10 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Actavis) 10 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Novotech) 200 mg/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Zithromax IV 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Kabi) 200 mg/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epiccord 50 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Act) 100 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Ebewe) 200 mg/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pharmorubicin 50 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Nexium IV 40 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Novotech) 20 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Mayne Pharma) 50 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (DBL) 200 mg/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Azithromycin (MaxRx) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Magnesium Sulfate Heptahydrate (Phebra) 5 g/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Novotech) 10 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Kabi) 50 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Actavis) 200 mg/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Ebewe) 50 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Phenasen 10 mg/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epicin 20 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epiccord 20 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Mayne Pharma) 100 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Azithromycin (DBL) 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Actavis) 10 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epicin 200 mg/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Azith 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Norcuron 10 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Tobra-day 500 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Tobramycin (DBL) 80 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Mixtard 30/70 injection, 1 x 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fungizone 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Nebcin 80 mg/2 mL injection, 10 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pronestyl 1 g/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Humulin 30/70 injection, 1 x 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Mixtard 50/50 injection, 1 x 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Tobramycin (DBL) 20 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Kepivance 6.25 mg powder for injection, 6 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Zoster Immunoglobulin-VF (CSL) 200 units injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Myozyme 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Panvax H1N1 Vaccine 2009 300 microgram/10 mL injection, 50 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Panvax H1N1 Vaccine 2009 300 microgram/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dilaudid-HP 500 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Panvax H1N1 Vaccine 2009 150 microgram/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Mozobil 24 mg/1.2 mL subcutaneous infusion injection, 1.2 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Leucovorin Calcium (Pfizer (Perth)) 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Benztropine Mesylate (Omega) 2 mg/2 mL injection, 10 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Capastat 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Leucovorin Calcium (DBL) 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Leucovorin Calcium (Pfizer (Perth)) 100 mg/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Leucovorin Calcium (Mayne Pharma) 300 mg/30 mL injection, 30 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Calcium Folinate (Ebewe) 300 mg/30 mL injection, 30 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dacarbazine (Sandoz) 100 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Leucovorin Calcium (DBL) 300 mg/30 mL injection, 30 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dacarbazine (Sandoz) 200 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Calcium Folinate (Ebewe) 100 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dacarbazine (Sandoz) 200 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dacarbazine (Sandoz) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Gentamicin (DBL) 80 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dacarbazine (Sandoz) 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dacarbazine (Sandoz) 100 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
B-Dose (Biological Therapies) injection: solution, 3 x 2.5 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Calcium Folinate (Ebewe) 1 g/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dacarbazine (DBL) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
B-Dose (Biological Therapies) injection, 3 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Retaane 15 mg/0.5 mL injection, 0.5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
B-Dose (Biological Therapies) injection, 6 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Mayne Pharma) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Optimark 3.31 g/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Menactra injection: solution, 0.5 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Sandoz) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
B-Dose (Biological Therapies) injection: solution, 6 x 2.5 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Optimark 1.65 g/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Mayne Pharma) 2 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Sandoz) 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Octreotide (Hospira) 500 microgram/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (DBL) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Octreotide (DBL) 500 microgram/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Hospira) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Optimark 4.96 g/15 mL injection, 15 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (DBL) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Optimark 6.62 g/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Octreotide (DBL) 50 microgram/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Sandoz) 500 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Octreotide (Hospira) 50 microgram/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Sandoz) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (DBL) 2 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (DBL) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Sandoz) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (DBL) 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Octreotide (DBL) 100 microgram/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (Hospira) 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefotaxime (DBL) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Octreotide (Hospira) 100 microgram/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|